NCT06286852

Brief Summary

Although eating disorders often occur during or after puberty, it is likely that critical antecedent conditions can be established before adolescence. The Eating Disorder Examination has been adapted for children and is described by Bryant - Waugh, Cooper, Taylor and Lask (1996). The EDE is considered the gold standard of measures of eating disorder psychopathology (Wilson, 1993), and this adaptation, which allows its use with a younger age group, is a potentially important addition to the assessment of eating disorders in children. The latest version of EDE, the l7th edition, has now surpassed its predecessors. The aim of the study is to evaluate the psychometric properties of the Child vers ion EDE (chEDE) translated into Italian, in a sample of patients with eating disorder

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
250

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2022

Geographic Reach
1 country

3 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2022

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 15, 2024

Completed
14 days until next milestone

First Posted

Study publicly available on registry

February 29, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2024

Completed
Last Updated

February 29, 2024

Status Verified

February 1, 2024

Enrollment Period

1.2 years

First QC Date

February 15, 2024

Last Update Submit

February 22, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • K-SADS-PL (Kiddie-Schedule for Affective Disorder and Schizophrenia-Present and Lifetime version) questionnaire

    K-SADS-PL score differences between experimental group (patients with eating disorders) and control group (adolescents without eating disorders)

    Immediately after the end of the study (last subject who will complete the qestionnaire)

  • ChEDE (Child Version of the EatingDisorder Examination)

    ChEDE score differences symptoms between patients with eating disorders and control group

    Immediately after the end of the study (last subject who will complete the qestionnaire)

Study Arms (2)

Experimental group

Subjects meeting a diagnosis of nutrition and eating disorder

Behavioral: Administration of K-SADS-PL- Kiddie-Schedule for Affective Disorder and Schizophrenia-Present and Lifetime version (Kaufmann, 2002)Behavioral: Administration of ChEDE- Child Version of the EatingDisorder Examination

Control group

children - adolescents from various schools in the Florence area, chosen through statistical criteria based on age, gender, ethnicity

Behavioral: Administration of ChEDE- Child Version of the EatingDisorder Examination

Interventions

Administration of 1) K-SADS-PL- Kiddie-Schedule for Affective Disorder and Schizophrenia-Present and Lifetime version (Kaufmann, 2002)

Experimental group

Administration of ChEDE- Child Version of the EatingDisorder Examination

Control groupExperimental group

Eligibility Criteria

Age8 Years - 17 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Subjects with a diagnosis of nutrition and eating disorder, particularly anorexia nervosa, bulimia nervosa, binge eating disorder, according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders DSM-5

You may qualify if:

  • Subjects meet a diagnosis of nutrition and eating disorder, specifically anorexia nervosa, bulimia nervosa, binge eating disorder, according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders DSM-5
  • Signed informed consent

You may not qualify if:

  • Schizophrenia or other psychotic disorders;
  • Substance misuse in place
  • Medical complications that have the potential to hinder interpretation of results ( e.g., a medical illness that induces weight loss)
  • Presence of physical treatments (including medications) that have the potential to hinder interpretation of results (e.g., chemotherapy for cancer)
  • or (for control group) Presence of a current or past eating disorder and/or Ongoing eating disorder therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Meyer Children's Hospital IRCCS

Florence, Italy

Location

USL Toscana Centro

Florence, Italy

Location

Ospedale Villa Garda

Garda, Italy

Location

MeSH Terms

Conditions

Feeding and Eating Disorders of Childhood

Condition Hierarchy (Ancestors)

Feeding and Eating DisordersMental Disorders

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 15, 2024

First Posted

February 29, 2024

Study Start

November 1, 2022

Primary Completion

December 30, 2023

Study Completion

June 30, 2024

Last Updated

February 29, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations